Companies

ACCENDRA HEALTH INC/VA/

ACH · CIK 0000075252 · operating

$2.39-1.24%Last updated Feb 27, 8:53 PM

Key Statistics

Valuation

Market Cap$187.18M
P/E
Fwd P/E2.29
PEG
P/S0.07
P/B
EV/EBITDA5.73
EV/Rev0.75

Profitability

Gross Margin
Op. Margin0.99%
Net Margin-39.85%
ROE238.76%
ROA-44.89%
FCF Margin

Financial Health

Current Ratio0.58
Debt/Equity-6.32
Free Cash Flow
Div. Yield

Growth & Other

Revenue Growth-74.19%
EPS Growth-202.54%
Beta1.34
52W High$10.43
52W Low$1.84

About ACCENDRA HEALTH INC/VA/

Based in Glen Allen, Virginia, Accendra Health operates as a medical device and supplies distributor focused on home and alternate-site care settings. The company supplies durable medical equipment and patient care products across multiple therapeutic categories, including diabetes management, respiratory therapy, sleep apnea treatment, wound care, and ostomy supplies. Its product portfolio encompasses continuous positive airway pressure (CPAP) and bi-level positive airway pressure (BiPAP) devices for obstructive sleep apnea, home oxygen and non-invasive ventilation services, negative pressure wound therapy systems, and various incontinence and urology products.

The company serves patients and home health agencies throughout the United States, operating as a wholesale distributor within the medical equipment and supplies sector. Accendra Health operates with approximately 6,500 full-time employees and maintains a market capitalization of $0.2 billion. The company was incorporated in Virginia and is publicly traded on the New York Stock Exchange.

Accendra Health was originally founded in 1882 under the name Owens & Minor, Inc., before undergoing a legal name change to Accendra Health, Inc. in December 2025. This rebranding reflected a strategic repositioning toward its core focus on home and alternate-site care delivery rather than broader healthcare distribution operations.

Earnings Per Share (Annual · SEC XBRL)

Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.

Fiscal YearEPS DilutedEPS BasicYoY
2025$-14.31$-14.31-202.5%
2024$-4.73$-4.73-775.9%
2023$-0.54$-0.54-286.2%
2022$0.29$0.30-90.1%
2021$2.94$3.05
2020
2019
2018
2017
2016$1.76$1.76+6.7%
2015$1.65$1.65+55.7%
2014$1.06$1.06-39.8%
2013$1.76$1.76+2.3%
2012$1.72$1.72-5.0%
2011$1.81$1.82+3.4%
2010$1.75$1.76

Annual Reports (10-K) · 10 filings

Report DateFiledAccession Number
2025-12-312026-02-200001104659-26-018169SEC ↗
2024-12-312025-02-280001558370-25-001940SEC ↗
2023-12-312024-02-200001558370-24-001369SEC ↗
2022-12-312023-02-280000075252-23-000010SEC ↗
2021-12-312022-02-230000075252-22-000009SEC ↗
2020-12-312021-02-240000075252-21-000034SEC ↗
2019-12-312020-03-040000075252-20-000021SEC ↗
2018-12-312019-03-060000075252-19-000037SEC ↗
2017-12-312018-02-230000075252-18-000042SEC ↗
2016-12-312017-02-170000075252-17-000037SEC ↗